• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishDashboard
    Quantisnow Logo

    © 2025 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI employees
    Legal
    Terms of usePrivacy policyCookie policy

    SEC Form SC 13D/A filed by Eagle Capital Growth Fund Inc. (Amendment)

    10/2/23 2:16:33 PM ET
    $GRF
    Finance/Investors Services
    Finance
    Get the next $GRF alert in real time by email
    SC 13D/A 1 ef20011662_sc13da.htm SC 13D/A

    UNITED STATES
    SECURITIES AND EXCHANGE COMMISSION
    Washington, D.C. 20549

    SCHEDULE 13D

    Under the Securities Exchange Act of 1934
    (Amendment No. 3)*

     
    Eagle Capital Growth Fund, Inc.
     
     
    (Name of Issuer)
     

     
    Common Stock
     
     
    (Title of Class of Securities)
     

     
    269451100
     
     
    (CUSIP Number)
     

     
    Luke E. Sims, 225 East Mason Street, Suite 802, Milwaukee WI  53202-3657; (414) 530-5680
     
     
    (Name, Address and Telephone Number of Person Authorized to
     
     
    Receive Notices and Communications)
     

     
    August 28, 2023
     
     
    (Date of Event which Requires Filing of this Statement)
     

    If the filing person has previously filed a statement on Schedule 13G to report the acquisition that is the subject of this Schedule 13D, and is filing this schedule because of Sections 240.13d-1(e), 240.13d-1(f) or 240.13d-1(g), check the following box. ☐

    Note: Schedules filed in paper format shall include a signed original and five copies of the schedule, including all exhibits. See Section 240.13d-7 for other parties to whom copies are to be sent.

    * The remainder of this cover page shall be filled out for a reporting person’s initial filing on this form with respect to the subject class of securities, and for any subsequent amendment containing information which would alter disclosures provided in a prior cover page.

    The information required on the remainder of this cover page shall not be deemed to be “filed” for the purpose of Section 18 of the Securities Exchange Act of 1934 (“Act”) or otherwise subject to the liabilities of that section of the Act but shall be subject to all other provisions of the Act (however, see the Notes).
     


    CUSIP No. 269451100
    13D
    Page 2 of 6 Pages
    1
    NAMES OF REPORTING PERSONS
     
     
    Luke E. Sims
     
     
     
     
    2
    CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP
    (a)
    ☐
    Not applicable
    (b)
    ☐
     
     
    3
    SEC USE ONLY
     
     
     
     
     
     
     
    4
    SOURCE OF FUNDS (SEE INSTRUCTIONS)
     
     
    PF
     
     
     
     
    5
    CHECK BOX IF DISCLOSURE OF LEGAL PROCEEDINGS IS REQUIRED PURSUANT TO ITEM 2(D) OR 2(E)
     
    ☐

     
     
     
     
    6
    CITIZENSHIP OR PLACE OF ORGANIZATION
     
     
    United States
     
     
     
     
    NUMBER OF SHARES BENEFICIALLY OWNED BY EACH REPORTING PERSON WITH
    7
    SOLE VOTING POWER
     
     
    280,271
     
     
     
     
    8
    SHARED VOTING POWER
     
     
    11,389
     
     
     
     
    9
    SOLE DISPOSITIVE POWER
     
     
    280,271
     
     
     
     
    10
    SHARED DISPOSITIVE POWER
     
     
    11,389
     
     
     
     
    11
    AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
     
     
     
     
     
     
     
    12
    CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (11) EXCLUDES CERTAIN SHARES (SEE INSTRUCTIONS)
     
    ☐
    291,660
     
     
     
     
    13
    PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (11)
     
     
    7.4%
     
     
     
     
    14
    TYPE OF REPORTING PERSON (SEE INSTRUCTIONS)
     
     
    Individual
     
     
     
     


    CUSIP No. 269451100
    13D
    Page 3 of 6 Pages

    Item 1.
    Security and Issuer.

    Common Stock, $0.001 par value (“Common Stock”)

    Eagle Capital Growth Fund, Inc.
    225 East Mason Street, Suite 802
    Milwaukee, WI   53202-3657


    Item 2.
    Identity and Background.

    (a) & (b) Luke E. Sims
    Chairman
    Sims Capital Management LLC
    225 East Mason Street, Suite 802
    Milwaukee, WI   53202-3657

    (O)   (414) 765-1107

    (Cell):   (414) 530-5680

    c)    Chairman
    Sims Capital Management LLC (SEC-    registered investment advisor)
    225 East Mason Street, Suite 802
    Milwaukee, WI   53202-3657

    President and Chief Executive Officer (and Director of)
    Eagle Capital Growth Fund, Inc.
    225 East Mason Street, Suite 802
    Milwaukee, WI   53202-3657

    Retired Partner
    Foley & Lardner LLP (law firm)
    777 East Wisconsin Avenue, Suite 3800
    Milwaukee, WI   53202

    (d)   Mr. Sims has never been convicted in a criminal proceeding.


    (e)
    Mr. Sims has never been a party to a civil proceeding of a judicial or administrative body of competent jurisdiction and as a result of such proceeding was or is subject to a judgment, decree or final order enjoining future violation of, or prohibiting or mandating activities subject to, federal or state securities laws or finding any violation with respect to such laws.


    (f)
    United States


    Item 3.
    Source and Amount of Funds or Other Consideration.

    PF


    CUSIP No. 269451100
    13D
    Page 4 of 6 Pages

    Item 4.
    Purpose of Transaction.

    Mr. Sims acquired the shares of Common Stock identified this filing for the purpose of investment.

    Mr. Sims is a Director, the President and Chief Executive Officer of the Issuer.

    Mr. Sims is also the Chairman and a principal of Sims Capital Management LLC, the investment advisor to the Issuer.


    (a)
    Not applicable.


    (b)
    Not applicable.


    (c)
    Not applicable.


    (d)
    Not applicable.


    (e)
    Not applicable.


    (f)
    Not applicable.


    (g)
    Not applicable.


    (h)
    Not applicable.


    (i)
    Not applicable.


    (j)
    Not applicable.


    Item 5.
    Interest in Securities of the Issuer.


    (a)
    Information concerning the number of shares and percentage of the class of Common Stock beneficially owned by the reporting person: (i) sole voting and dispositive power (280,271); (ii) shared voting and dispositive power (11,389); (iii) aggregate beneficial ownership (291,660); (iv) percentage of class of Common Stock (7.4%).


    (b)
    See response to (a) above.


    (c)
    Set forth below is information with respect to the sole transaction with respect to the Common Stock by Mr. Sims (and reflected in Mr. Sims’ beneficial ownership) during the past sixty (60) days.

    On August 28, 2023, Mr. Sims sold five thousand (5,000) shares of Common Stock in the open market at a sale price of $8.88 per share.


    (d)
    Not applicable.


    (e)
    Not applicable.


    CUSIP No. 269451100
    13D
    Page 5 of 6 Pages

    Item 6.
    Contracts, Arrangements, Understandings or Relationships With Respect to Securities of the Issuer.

    Mr. Sims is a Director, President and Chief Executive Officer of the Issuer
    CUSIP No. 269451100

    Mr. Sims is also the Chairman and a 50% equity owner of Sims Capital Management LLC, an SEC-registered investment advisor (“SCM).   SCM is the investment advisor to the Issuer.


    Item 7.
    Material to be Filed as Exhibits.

    None


    CUSIP No. 269451100
    13D
    Page 6 of 6 Pages
    SIGNATURE
     
    After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct.


    /s/

    Luke E. Sims

     

    Luke E. Sims

    (Title)

    September 28, 2023

    (Date)



    Get the next $GRF alert in real time by email

    Chat with this insight

    Save time and jump to the most important pieces.

    Recent Analyst Ratings for
    $GRF

    DatePrice TargetRatingAnalyst
    More analyst ratings

    $GRF
    Leadership Updates

    Live Leadership Updates

    See more
    • Grifols 2022 Annual Report on Form 20-F filed with the SEC on April 18, 2023

      BARCELONA, Spain, April 18, 2023 /PRNewswire/ -- Grifols, S.A. ("Grifols") (MCE: GRF) (MCE: GRF.P) (NASDAQ:GRFS), a global healthcare company and leading manufacturer of plasma-derived medicines that has been enhancing people's health and well-being for more than 110 years, today announces the filling of its Annual Report on Form 20-F for the fiscal year ended December 31, 2022, with the United States Securities and Exchange Commission ("SEC"). Grifols' annual report under Form 20-F is a critical component of the company's commitment to transparency and accountability. The filing of the annual report provides investors with an overview of the company's governance practices, including informa

      4/18/23 10:30:00 AM ET
      $GRF
      $GRFS
      Finance/Investors Services
      Finance
      Biotechnology: Pharmaceutical Preparations
      Health Care

    $GRF
    Press Releases

    Fastest customizable press release news feed in the world

    See more
    • Eagle Capital Growth Fund Declares Year-End Distribution of $0.68 Per Share in Cash

      The Eagle Capital Growth Fund, Inc. ("Fund") (NYSE:GRF) today declared a year-end distribution of $0.68 per share in cash. The record date for this distribution is November 29, 2024, and the payment date is December 19, 2024. On a preliminary basis, this distribution represents a combination of net investment income of $0.0754 per share, and long-term capital gains of $0.6046 per share. This preliminary information is subject to change. Shareholders will receive definitive information with respect to U. S. Federal income tax treatment. In addition, shareholders can access definitive tax information by going to the Fund's website after year-end. The Fund is a closed-end investment compan

      11/18/24 4:00:00 PM ET
      $GRF
      Finance/Investors Services
      Finance
    • Eagle Capital Growth Fund Declares Year-End Distribution of $0.35 Per Share in Cash

      The Eagle Capital Growth Fund, Inc. ("Fund") (NYSE:GRF) today declared a year-end distribution of $0.35 per share in cash. The record date for this distribution is November 24, 2023, and the payment date is December 15, 2023. On a preliminary basis, this distribution represents a combination of net investment income of $0.07 per share, short-term capital gains of $0.03 per share, and long-term capital gains of $0.25 per share. This preliminary information is subject to change. Shareholders will receive definitive information with respect to U. S. Federal income tax treatment. In addition, shareholders can access definitive tax information by going to the Fund's website after year-end. T

      10/13/23 5:30:00 PM ET
      $GRF
      Finance/Investors Services
      Finance
    • Grifols 2022 Annual Report on Form 20-F filed with the SEC on April 18, 2023

      BARCELONA, Spain, April 18, 2023 /PRNewswire/ -- Grifols, S.A. ("Grifols") (MCE: GRF) (MCE: GRF.P) (NASDAQ:GRFS), a global healthcare company and leading manufacturer of plasma-derived medicines that has been enhancing people's health and well-being for more than 110 years, today announces the filling of its Annual Report on Form 20-F for the fiscal year ended December 31, 2022, with the United States Securities and Exchange Commission ("SEC"). Grifols' annual report under Form 20-F is a critical component of the company's commitment to transparency and accountability. The filing of the annual report provides investors with an overview of the company's governance practices, including informa

      4/18/23 10:30:00 AM ET
      $GRF
      $GRFS
      Finance/Investors Services
      Finance
      Biotechnology: Pharmaceutical Preparations
      Health Care

    $GRF
    SEC Filings

    See more
    • SEC Form DEF 14A filed by Eagle Capital Growth Fund Inc.

      DEF 14A - EAGLE CAPITAL GROWTH FUND, INC. (0000850027) (Filer)

      3/6/25 12:38:23 PM ET
      $GRF
      Finance/Investors Services
      Finance
    • SEC Form N-CSR filed by Eagle Capital Growth Fund Inc.

      N-CSR - EAGLE CAPITAL GROWTH FUND, INC. (0000850027) (Filer)

      3/6/25 12:30:43 PM ET
      $GRF
      Finance/Investors Services
      Finance
    • SEC Form N-CEN filed by Eagle Capital Growth Fund Inc.

      N-CEN - EAGLE CAPITAL GROWTH FUND, INC. (0000850027) (Filer)

      2/28/25 10:29:16 AM ET
      $GRF
      Finance/Investors Services
      Finance

    $GRF
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    See more
    • CFO, CCO, Secretary, Treasurer Sims David C bought $53,726 worth of shares (5,535 units at $9.71), increasing direct ownership by 2% to 199,897 units (SEC Form 4)

      4 - EAGLE CAPITAL GROWTH FUND, INC. (0000850027) (Issuer)

      5/2/25 2:29:09 PM ET
      $GRF
      Finance/Investors Services
      Finance
    • CFO, CCO, Secretary, Treasurer Sims David C bought $49,062 worth of shares (5,164 units at $9.50), increasing direct ownership by 3% to 196,837 units (SEC Form 4)

      4 - EAGLE CAPITAL GROWTH FUND, INC. (0000850027) (Issuer)

      4/11/25 2:04:26 PM ET
      $GRF
      Finance/Investors Services
      Finance
    • Allen Jason W. increased direct ownership by 35% to 3,338 units (SEC Form 5)

      5 - EAGLE CAPITAL GROWTH FUND, INC. (0000850027) (Issuer)

      2/14/25 1:48:10 PM ET
      $GRF
      Finance/Investors Services
      Finance

    $GRF
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    See more
    • SEC Form SC 13D filed by Eagle Capital Growth Fund Inc.

      SC 13D - EAGLE CAPITAL GROWTH FUND, INC. (0000850027) (Subject)

      10/2/23 2:30:30 PM ET
      $GRF
      Finance/Investors Services
      Finance
    • SEC Form SC 13D/A filed by Eagle Capital Growth Fund Inc. (Amendment)

      SC 13D/A - EAGLE CAPITAL GROWTH FUND, INC. (0000850027) (Subject)

      10/2/23 2:16:33 PM ET
      $GRF
      Finance/Investors Services
      Finance

    $GRF
    Insider Purchases

    Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

    See more
    • CFO, CCO, Secretary, Treasurer Sims David C bought $53,726 worth of shares (5,535 units at $9.71), increasing direct ownership by 2% to 199,897 units (SEC Form 4)

      4 - EAGLE CAPITAL GROWTH FUND, INC. (0000850027) (Issuer)

      5/2/25 2:29:09 PM ET
      $GRF
      Finance/Investors Services
      Finance
    • CFO, CCO, Secretary, Treasurer Sims David C bought $49,062 worth of shares (5,164 units at $9.50), increasing direct ownership by 3% to 196,837 units (SEC Form 4)

      4 - EAGLE CAPITAL GROWTH FUND, INC. (0000850027) (Issuer)

      4/11/25 2:04:26 PM ET
      $GRF
      Finance/Investors Services
      Finance
    • Amendment: Director Bilkie Robert M disposed of 1,764 shares, acquired 1,764 shares and bought $5,574 worth of shares (600 units at $9.29) (SEC Form 4)

      4/A - EAGLE CAPITAL GROWTH FUND, INC. (0000850027) (Issuer)

      2/14/25 1:29:17 PM ET
      $GRF
      Finance/Investors Services
      Finance